The aim of this study was to determine the levels of serum FGF23 in pregnancies complicated with GHD and investigate FGF23 levels in preeclampsia, eclampsia, GHT, and the presence of fetal growth restriction (FGR) subgroups. The gene discussed is FGF23; the disease is fetal growth restriction.